Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis

Keyphrases

• Rheumatoid Arthritis 100%
• Combined Treatment 100%
• Etanercept 100%
• Omalizumab 100%
• Chronic Spontaneous Urticaria 100%
• Disease Activity 50%
• Patient Selection 50%
• Inflammatory Diseases 50%
• Long-term Adverse Effects 50%
• No Adverse Effect 50%
• Older Female Patient 50%
• Combined Biologic Therapy 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Rheumatoid Arthritis 100%
• Etanercept 100%
• Omalizumab 100%
• Chronic Urticaria 100%
• Side Effect 50%
• Disease Activity 50%
• Adverse Event 50%
• Inflammatory Disease 50%

Immunology and Microbiology

• Inflammatory Arthritis 100%
• Etanercept 100%
• Omalizumab 100%
• Chronic Urticaria 100%
• Inflammatory Disorder 50%